Skip to content

Join our community and subscribe to our free weekly newsletter

Subscribe
  • Latest News
    • Articles
    • Live Talks
    • Trials Update
  • Prevention & Risk Factors
    • Science-Backed Dementia Prevention
    • Alzheimer’s Genetics & Risk Factors
    • Menopause
    • Long COVID
  • Dementias
    • Alzheimer’s Disease
    • Vascular Dementia
    • Frontotemporal Dementia (FTD)
    • Lewy Body Dementia
    • Traumatic Brain Injury & CTE
  • Brain Disorders
    • Mild Cognitive Impairment (MCI)
    • Parkinson’s Disease
  • Getting Diagnosed
    • Diagnosis
    • Journey to Diagnosis
    • Genetic Testing
    • Alzheimer’s Biomarkers
    • Diversity and Dementia
  • Caregivers
    • Caregiver Voices
  • Learning Guides

Simon Spichak, MSc

  • more-comfortable-end-of-life-care-for-alzheimer-dementia-alzheier's-death

    Before Alzheimer’s Death, Making Last Days More Comfortable

  • race-norming, cognitive test

    Race-Norming: Cognitive Tests Were Designed Based on Racist Beliefs

  • Neurogenesis: Helping the Brain Grow New Cells in Alzheimer’s

  • microglia dementia, TREM2

    Meet Microglia, the Brain’s Alzheimer’s-Fighting Sculptors

  • gum disease Alzheimer's

    Targeting Gingivitis-Causing Bacteria to Treat Alzheimer’s

  • probiotics brain health, microbiome

    Should You Take Probiotics for Brain Health?

  • The Centers for Medicare and Medicaid Services clarify their memo the big question: Will Medicare cover Aduhelm? aduhelm insurance coverage, CMS

    Will Medicare Cover Aduhelm? Translating the CMS’s ‘Very Confusing’ Plan

  • nootropics

    The Truth About Brain Boosting Supplements

  • The CMS Wants Your Input on Aduhelm Coverage—Here’s How To Comment

  • Why Is Everyone So Mad About Aduhelm?

  • Medicare Limits Aduhelm Coverage

  • alzheimer's vaccination, immunotherapy

    At Least 9 Alzheimer’s Vaccines in Trials Right Now

  • TRAILBLAZER 3, donanemab, anti-amyloid

    Why Alzheimer’s Trials Are Recruiting Younger Patients

  • Alzheimer's treatments, disease-modifying treatment, symptomatic treatment. What’s the difference between treating Alzheimer’s symptoms and modifying the disease?

    How New Alzheimer’s Drugs Are Changing the Game

  • aducanumab aduhelm alzheimer's drug approval

    Biogen Slashes Aduhelm Price; EMA Rejects It in EU

Previous272829Next

Sign up for our weekly newsletter

Subscribe to get the latest and most trusted brain health science and news, straight to your inbox.

Sign Up

Copyright © 2026 Being Patient

Join Our Community

Get brain health and dementia news, storytelling, and expert insights right to your inbox. Sign up for our free weekly newsletter.

You're in! Thanks for subscribing — our free weekly newsletter is coming your way.
You’re already subscribed to our newsletter.

About Being Patient

  • Advisors
  • Contribute
  • About Us
  • Partnerships
  • Contact Us
  • Press
  • Glossary

Legal

  • Terms & Conditions
  • Privacy Policy
  • AI Policy
  • Republishing Our Content
Copyright © 2026 Being Patient

Social Media

  • Instagram 
  • Facebook
  • LinkedIn
  • YouTube
  • TikTok
  • X
Copyright © 2026 Being Patient

Page load link
Go to Top